Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MEGESTROL 40 MG TABLET

Megestrol Acetate
$0.2385per EA

Strength

40 mg/1

Manufacturer

Teva Pharmaceuticals USA Inc.

NDC

00555060702

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MEGESTROL ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA074621

On Market Since

11/30/1995

Pharmacological Classes

Progesterone Congeners
Progestin

Price History

1W

0.0%

1M

-1.2%

3M

+4.3%

6M

+14.0%

1Y

+25.3%

3Y

+13.8%

5Y

+33.4%

All

+41.0%

Generic Alternatives

2 alternatives • Same active ingredient

MEGESTROL 40 MG TABLET
Generic
00904723661•Major Pharmaceuticals
$0.2385
MEGESTROL 40 MG TABLET
Generic
64380015902•Strides Pharma Inc.
$0.2385

Related Drugs

Same classification

NORETHINDRONE 0.35 MG TABLET
Generic
00378727253•Mylan Pharmaceuticals Inc.
$0.0922
per EA
NORETHINDRONE 0.35 MG TABLET
Generic
00378729253•Mylan Pharmaceuticals Inc.
$0.0922
per EA
NORA-BE TABLET
Generic
00480347516•Teva Pharmaceuticals USA Inc.
$0.0922
per EA
LYLEQ 0.35 MG TABLET
Generic
50102030013•Afaxys Pharma, LLC
$0.0922
per EA
CAMILA 0.35 MG TABLET
Generic
51862088403•Mayne Pharma
$0.0922
per EA
ERRIN 0.35 MG TABLET
Generic
51862088603•Mayne Pharma
$0.0922
per EA
NORA-BE TABLET
Generic
52544062928•Actavis Pharma, Inc.
$0.0922
per EA
EMZAHH 0.35 MG TABLET
Generic
59651013628•Aurobindo Pharma Limited
$0.0922
per EA
EMZAHH 0.35 MG TABLET
Generic
59651013688•Aurobindo Pharma Limited
$0.0922
per EA
INCASSIA 0.35 MG TABLET
Generic
65862092528•Aurobindo Pharma Limited
$0.0922
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy